Scoring Systems

Evidence-based staging and risk stratification calculators for cutaneous malignancies. Select a scoring system below.

Privacy: All calculations are performed locally in your browser. No patient data is transmitted, stored, or shared.

This platform is not a HIPAA Business Associate. Do not enter identifiable patient information.

BWH Tumor Staging for cSCC

Brigham and Women's Hospital T-staging system for cutaneous squamous cell carcinoma. Check all risk factors that apply.

Tumor diameter >= 2 cmPoorly differentiated histologyPerineural invasion (>= 0.1 mm caliber nerve)Tumor invasion beyond subcutaneous fat

Risk factor score0 / 4

Result

T1 -- Low Risk

Estimated metastatic rate< 1%

No high-risk features identified. Low metastatic potential.

References

Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol. 2014;32(4):327-334.
Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149(5):541-547.

For clinical decision support only. These scoring systems are educational aids. All clinical decisions remain the sole responsibility of the treating physician. Not validated as a medical device.